Kiniksa Pharmaceuticals International, plc
KNSA
43 insider filings · Latest: Sep 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Jun 16 9:23 PM | Tessari Eben | Proposed Sale | 17,300 | $28.28 | $489.2K | — | View → |
| Jun 11, 2025 | Jun 11 8:39 PM | Tessari Eben | Proposed Sale | 45,042 | $30.51 | $1.4M | — | View → |
| Jun 10, 2025 | Jun 10 9:46 PM | Tessari Eben | Proposed Sale | 15,506 | $30.46 | $472.2K | — | View → |
| Jun 9, 2025 | Jun 9 9:09 PM | Tessari Eben | Proposed Sale | 10,319 | $30.38 | $313.5K | — | View → |
| Jun 9, 2025 | Jun 9 9:08 PM | Quart Barry D | Proposed Sale | 27,448 | $30.26 | $830.6K | — | View → |
| Jun 3, 2025 | Jun 3 8:36 PM | Megna Michael R | Proposed Sale | 15,211 | $28.75 | $437.3K | — | View → |
| Jun 3, 2025 | Jun 3 8:35 PM | Moat Ross | Proposed Sale | 27,594 | $29.02 | $800.9K | — | View → |
| Jun 3, 2025 | Jun 3 8:34 PM | Ragosa Mark | Proposed Sale | 18,299 | $28.80 | $527.0K | — | View → |
| May 19, 2025 | May 19 9:16 PM | Tessari Eben | Proposed Sale | 12,000 | $26.41 | $316.9K | — | View → |
| May 7, 2025 | May 7 9:13 PM | Patel Sanj K | Proposed Sale | 99,586 | $27.00 | $2.7M | — | View → |
| May 7, 2025 | May 7 8:59 PM | Paolini John F. | Proposed Sale | 29,525 | $27.00 | $797.2K | — | View → |
| May 7, 2025 | May 7 8:00 PM | Megna Michael R | Proposed Sale | 17,647 | $26.69 | $471.0K | — | View → |
| May 5, 2025 | May 5 8:11 PM | Moat Ross | Proposed Sale | 6,272 | $28.00 | $175.6K | — | View → |
| May 2, 2025 | May 2 9:01 PM | Moat Ross | Proposed Sale | 3,850 | $28.01 | $107.8K | — | View → |
| May 1, 2025 | May 1 9:11 PM | Ragosa Mark | Proposed Sale | 25,141 | $27.80 | $698.9K | — | View → |
| May 1, 2025 | May 1 9:10 PM | Moat Ross | Proposed Sale | 23,234 | $28.02 | $650.9K | — | View → |
| Apr 30, 2025 | Apr 30 8:32 PM | Ragosa Mark | Proposed Sale | 21,254 | $26.95 | $572.8K | — | View → |
| Apr 29, 2025 | Apr 29 8:29 PM | Moat Ross | Proposed Sale | 64,035 | $25.21 | $1.6M | — | View → |
| Apr 29, 2025 | Apr 29 8:29 PM | Ragosa Mark | Proposed Sale | 42,000 | $25.61 | $1.1M | — | View → |
| Apr 21, 2025 | Apr 21 8:06 PM | Moat Ross | Proposed Sale | 18,259 | $20.29 | $370.4K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Sep 3 8:49 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 9,104 | — | 0(D) | View → |
| Sep 1, 2026 | Sep 3 8:49 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Grant/Award | 38,950 | $79.28 | 31,150(D) | View → |
| Sep 1, 2026 | Sep 3 8:48 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Grant/Award | 150,200 | $79.28 | 120,150(D) | View → |
| Sep 1, 2026 | Sep 3 8:48 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Option Exercise | 31,318 | — | 0(D) | View → |
| Sep 1, 2026 | Sep 3 8:46 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Grant/Award | 150,200 | $79.28 | 120,150(D) | View → |
| Sep 1, 2026 | Sep 3 8:46 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Option Exercise | 31,318 | — | 0(D) | View → |
| Sep 1, 2026 | Sep 3 8:43 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Option Exercise | 8,328 | — | 0(D) | View → |
| Sep 1, 2026 | Sep 3 8:43 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Grant/Award | 33,450 | $79.28 | 26,750(D) | View → |
| Sep 1, 2026 | Sep 3 8:41 PM | Ross MoatCHIEF OPERATING OFFICER | Option Exercise | 8,285 | — | 0(D) | View → |
| Sep 1, 2026 | Sep 3 8:41 PM | Ross MoatCHIEF OPERATING OFFICER | Grant/Award | 46,200 | $79.28 | 36,950(D) | View → |
| Sep 1, 2026 | Sep 3 8:40 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Grant/Award | 18,250 | $79.28 | 14,600(D) | View → |
| Sep 1, 2026 | Sep 3 8:40 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Option Exercise | 11,496 | — | 0(D) | View → |
| Aug 1, 2026 | Aug 4 8:40 PM | Richard S LevyDirector | Grant/Award | 403 | — | 403(D) | View → |
| Aug 1, 2026 | Aug 4 8:40 PM | Richard S LevyDirector | Option Exercise | 403 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 8:42 PM | Dhiraj H MalkaniCHIEF STRATEGY OFFICER | Grant/Award | 103,459 | $62.88 | 0(D) | View → |
| May 29, 2026 | Jun 2 8:52 PM | Barry D QuartDirector | Option Exercise | 2,799 | — | 0(D) | View → |
| May 29, 2026 | Jun 2 8:52 PM | Barry D QuartDirector | Grant/Award | 14,184 | $48.38 | 2,026(D) | View → |
| May 29, 2026 | Jun 2 8:51 PM | Kimberly J PopovitsDirector | Option Exercise | 2,799 | — | 0(D) | View → |
| May 29, 2026 | Jun 2 8:51 PM | Kimberly J PopovitsDirector | Grant/Award | 14,184 | $48.38 | 2,026(D) | View → |
| Jun 1, 2026 | Jun 2 8:50 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Conversion | 900,000 | — | 626,160(I) | View → |
Page 1 of 4
Next →